NCT06804850 2025-11-19
Neoadjuvant Radiotherapy Plus Targeted Therapy and Immunotherapy vs. Targeted Therapy Plus Immunotherapy in Resectable HNSCC
West China Hospital
Phase 2 Withdrawn
West China Hospital
Thomas Jefferson University
Eurofarma Laboratorios S.A.
BioMimetix JV, LLC
SWOG Cancer Research Network
AstraZeneca